USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
MARKER GENE TECHNOLOGIES, INC
Address:
1850 MILLRACE DRIVE
1850 MILLRACE DRIVE
EUGENE, OR 97403 1992
Phone:
(541) 342-3760
URL:
N/A
EIN:
931228900
DUNS:
869195859
Number of Employees:
8
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
Yes

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,270,202.00 10
SBIR Phase II $1,526,581.00 3

Award List:

SBIR Phase I: Marker Gene Directed Substrates for Cell Regulation

Award Year / Program / Phase:
1996 / SBIR / Phase I
Award Amount:
$74,175.00
Agency:
NSF
Principal Investigator:
John Naleway
Abstract:
N/a

MARKER GENE DIRECTED SUBSTRATES FOR CELL REGULATION

Award Year / Program / Phase:
1996 / SBIR / Phase I
Award Amount:
$99,850.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

SBIR Phase I: Marker Gene Directed Substrates for Cell Regulation

Award Year / Program / Phase:
1997 / SBIR / Phase II
Award Amount:
$298,940.00
Agency:
NSF
Principal Investigator:
John Naleway
Abstract:
N/a

Genetic Strategies for Drug Targeting

Award Year / Program / Phase:
1998 / SBIR / Phase II
Award Amount:
$727,752.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$99,485.00
Agency:
NSF
Principal Investigator:
John Naleway
Abstract:
N/a

LIVE CELL APOPTOSIS ASSAY FOR HIGH-THROUGHPUT SCREENING

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$97,406.00
Agency:
HHS
Principal Investigator:
John J. Naleway
Abstract:
DESCRIPTION (Applicant's Abstract): This Small Business Innovation Research Phase I project aims to investigate the feasibility of developing new compounds capable of measuring initial stages of apoptosis induction in living cells and tissues. If successful, the proposed research… More

SBIR/STTR Phase I: New GUS Substrates for Cell Regulation

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$99,972.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project is to develop commercial uses for conjugates capable of exploiting cloned gene expression in transformed plant cells to control their growth and physiology. The specific goal of this project is to synthesize a series of new… More

NEW LABELING REAGENTS FOR GENETIC ANALYSIS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$99,982.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to investigate the feasibility of developing new, sensitive, accurate, and reliable detection methods for genomic DNA or RNA samples that are essential for genomic microarray analysis. If successful,… More

LUCIFERASE DIRECTED SUBSTRATES FOR CELL REGULATION

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$99,850.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to investigate the feasibility of developing new compounds capable of utilizing common marker gene expression in transformed cells to control the growth and character of cells in living tissue. If… More

POSITIVE SELECTION SYSTEMS USING MARKER GENES

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$99,879.00
Agency:
HHS
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase I project aims to investigate the feasibility of developing new compounds capable of utilizing common marker gene expression in transformed cells to control the growth and character of cells in cell culture and live tissue applications. If successful,… More

Live-Cells Assays for Lysosomal Enzyme Activity

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$399,644.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to develop new targeted fluorogenic substrates capable of measuring lysosomal enzyme activity in living cells and tissues. If successful, the proposed researc h will provide breakthroughs needed to… More

SBIR Phase I: New Labeling Reagents for Genetic Analysis

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$99,959.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I research project aims to develop novel nucleic acid labeling reagents that can be used in living cells to monitor gene expression. Instead of relying on labeling the molecules using fluorescently labeled bases, the proposed approach relies on… More

SBIR Phase II: New Labeling Reagents for Genetic Analysis

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$499,889.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase II project aims to develop new, sensitive, accurate, and reliable detection methods for measuring genomic DNA or RNA samples isolated from living cells. The intellectual merit of this project lies in the development of new detection methods that are… More